Initial award HD 15-1098, joint product manager medical countermeasure systems, joint vaccine acquisitions program, advanced filovirus vaccine development and advancement of contributing platforms for…
Ended Awarded Last action
- Contract number
- 0004
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
Defense Contract Management Agency
Department of Defense
- Obligated
- $12,232,204
Award facts
- Opportunity
-
- FA807512R0002 Solicitation number
- Homeland Defense and Security Technical Area Tasks (HDTATs) Award Notice · Posted Feb 9, 2012
- Contract value 100% obligated
- $12,284,540.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Air Force Materiel Command Air Force, Department of Defense
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,268 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $2,166,687 | |
| Funding Only Action | $900,069 | |
| Funding Only Action | $1,140,576 | |
| Funding Only Action | $2,270,030 | |
| Funding Only Action | $272,430 | |
| Funding Only Action | $1,483,680 | |
| Original award | $4,000,000 |
About this award
This is a delivery order issued against the Homeland Defense and Security Technical Area Tasks (HD TATs) indefinite-delivery indefinite-quantity (IDIQ) contract, which is held by the U.S. Air Force Materiel Command. The $12,284,540.00 contract was awarded to Battelle Memorial Institute, a non-profit research and development organization, to support the Joint Vaccine Acquisitions Program's advanced filovirus vaccine development and continued medical countermeasures research. The contract involves vaccine R&D, including a clinical Phase 1 trial and good manufacturing practice (GMP) production of rVSVN4CT1 vectored Ebola-Sudan and Marburg-Angola vaccines. Battelle is working with subcontractors Profectus Biosciences, a small business specializing in vaccine development, and Mimotopes, a manufacturer, to execute the technical requirements. This award does not utilize any set-aside designations.
Description
Initial award HD 15-1098, joint product manager medical countermeasure systems, joint vaccine acquisitions program, advanced filovirus vaccine development and advancement of contributing platforms for continued medical countermeasures research
Quick answers
Who was awarded contract 0004?
0004 was awarded to Battelle Memorial Institute by Defense Contract Management Agency (Department of Defense) on May 20, 2015.
How much is contract 0004 worth?
The government has obligated $12,232,204 on 0004. Its current value, with exercised options, is $12,284,540.
Which agency awarded contract 0004?
Defense Contract Management Agency (Department of Defense) awarded 0004, with funding from Air Force Materiel Command (Air Force).
Is contract 0004 an order under another contract?
Yes. 0004 is a delivery order under FA807514D0003, an indefinite delivery contract, on Homeland Defense and Security Technical Area Tasks (HD TATs).
Was contract 0004 competed?
The extent of competition for 0004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award